PAPER Collin M, Bonnet-Chateau J, Gilles V, Dautricourt S, Gilbert T, Makaroff Z, Coste MH, Dauphinot V, Garnier-Crussard A

Intrinsic capacity in patients with dementia with Lewy bodies compared with those with Alzheimer's disease: A cross-sectional study.

J Nutr Health Aging. 2025 Mar 22;29(6):100541. Epub 2025 Mar 22 PubMed.

PAPER Ji D, Zhang J, Liang J, Huang ZS, Shu B, Li D

Efficient strategy for alleviating neuronal apoptosis and oxidative stress damage of Alzheimer's disease through dual targeting BCL-2 gene promoter i-motif and β-amyloid.

Redox Biol. 2025 Mar 18;82:103600. Epub 2025 Mar 18 PubMed.

PAPER Koeglsperger T, Berberovic E, Dresel C, Haferkamp S, Kassubek J, Müller R, Oehlwein C, Paus S, Urban PP

Real-world experience with continuous subcutaneous foslevodopa/foscarbidopa infusion: insights and recommendations.

J Neural Transm (Vienna). 2025 Mar 22; Epub 2025 Mar 22 PubMed.

PAPER El Hajjar L, Boll E, Cantrelle FX, Bridot C, Landrieu I, Smet-Nocca C

Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments.

Sci Rep. 2025 Mar 22;15(1):9975. PubMed.

PAPER Zhao J, Gu T, Gao C, Miao G, Palma-Gudiel H, Yu L, Yang J, Wang Y, Li Y, Lim J, Li R, Yao B, Wu H, Schneider JA, Seyfried N, Grodstein F, De Jager PL, Jin P, Bennett DA

Brain 5-hydroxymethylcytosine alterations are associated with Alzheimer's disease neuropathology.

Nat Commun. 2025 Mar 22;16(1):2842. PubMed.

PAPER Wang MT, Wang YR, Zeng GH, Zeng XQ, Fei ZC, Chen J, Zhou J, Li XP, Xu ZQ, Wang YJ, Liu YH

Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease.

J Prev Alzheimers Dis. 2025 Mar 21;:100135. Epub 2025 Mar 21 PubMed.

PAPER Zhang X, Wang J, Zhang J, Jiang C, Liu X, Wang S, Zhang Z, Rastegar-Kashkooli Y, Dialameh F, Peng Q, Tao J, Ding R, Wang J, Cheng N, Wang M, Wang F, Li N, Xing N, Chen X, Fan X, Wang J, Wang J

Humanized rodent models of neurodegenerative diseases and other brain disorders.

Neurosci Biobehav Rev. 2025 Mar 20;172:106112. Epub 2025 Mar 20 PubMed.

PAPER Kunze LH, Palumbo G, Gnörich J, Wind-Mark K, Schaefer R, Lindner S, Gildehaus FJ, Ziegler S, Brendel M

Fibrillar amyloidosis and synaptic vesicle protein expression progress jointly in the cortex of a mouse model with β-amyloid pathology.

Neuroimage. 2025 Mar 20;310:121165. Epub 2025 Mar 20 PubMed.

PAPER Bonfili L, Grasselli FM, Cuccioloni M, Cecarini V, Lufrano D, Vittadini E, Galosi L, Sonsini G, Ubaldi M, Turck JL, Medina LF, Suchodolski J, Eleuteri AM

A red lentils-based synbiotic cookie exerts neuroprotective effects in a mouse model of Alzheimer's disease.

J Nutr Biochem. 2025 Mar 20;:109904. Epub 2025 Mar 20 PubMed.

PAPER Chen J, Xu S, Wang L, Liu X, Liu G, Tan Q, Li W, Zhang S, Du Y

Refining the interactions between microglia and astrocytes in Alzheimer's disease pathology.

Neuroscience. 2025 Mar 20;573:183-197. Epub 2025 Mar 20 PubMed.

PAPER Jain S, Murmu A, Chauhan A

Advancing Alzheimer's disease therapy through engineered exosomal Macromolecules.

Brain Res. 2025 Mar 20;1855:149590. Epub 2025 Mar 20 PubMed.

PAPER Moosavi SG, Rahiman N, Jaafari MR, Arabi L

Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases.

J Control Release. 2025 Mar 20;381:113641. Epub 2025 Mar 20 PubMed.

PAPER Altun S, Özdemir S, Arslan H, Kiliçlioğlu M, Yaprak E, Bolat İ, Aydın Ş

Impact of long-term deltamethrin exposure on Alzheimer's-related neurodegeneration in rats.

Exp Neurol. 2025 Mar 20;388:115223. Epub 2025 Mar 20 PubMed.

PAPER Bateman RJ, Li Y, McDade EM, Llibre-Guerra JJ, Clifford DB, Atri A, Mills SL, Santacruz AM, Wang G, Supnet C, Benzinger TL, Gordon BA, Ibanez L, Klein G, Baudler M, Doody RS, Delmar P, Kerchner GA, Bittner T, Wojtowicz J, Bonni A, Fontoura P, Hofmann C, Kulic L, Hassenstab J, Aschenbrenner AJ, Perrin RJ, Cruchaga C, Renton AE, Xiong C, Goate AA, Morris JC, Holtzman DM, Snider BJ, Mummery C, Brooks WS, Wallon D, Berman SB, Roberson E, Masters CL, Galasko DR, Jayadev S, Sanchez-Valle R, Pariente J, Kinsella J, van Dyck CH, Gauthier S, Hsiung GR, Masellis M, Dubois B, Honig LS, Jack CR, Daniels A, Aguillón D, Allegri R, Chhatwal J, Day G, Fox NC, Huey E, Ikeuchi T, Jucker M, Lee JH, Levey AI, Levin J, Lopera F, Roh J, Rosa-Neto P, Schofield PR, Dominantly Inherited Alzheimer's Disease–Trials Unit

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.

Lancet Neurol. 2025 Apr;24(4):316-330. PubMed.

PAPER Schott JM

Amyloid immunotherapy to prevent Alzheimer's disease: the wrong drug at the right time?

Lancet Neurol. 2025 Apr;24(4):279-281. PubMed.